Balyasny Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$927K Sell
259,007
-141,699
-35% -$563K ﹤0.01% 2110
2025
Q4
$1.41M Sell
400,706
-913,031
-69% -$3.13M ﹤0.01% 2030
2025
Q3
$4.28M Buy
1,313,737
+1,181,931
+897% +$3.72M 0.01% 1434
2025
Q2
$323K Sell
131,806
-221,151
-63% -$1.12M ﹤0.01% 2456
2025
Q1
$2.35M Buy
+352,957
New +$3.49M 0.01% 1630
2023
Q4
Sell
-34,205
Closed -$701K 2847
2023
Q3
$701K Buy
+34,205
New +$622K ﹤0.01% 1657
2023
Q1
Sell
-542
Closed -$10.6K 3093
2022
Q4
$10.6K Sell
542
-49,228
-99% -$907K ﹤0.01% 2551
2022
Q3
$794K Buy
+49,770
New +$777K ﹤0.01% 1891
2017
Q1
Sell
-18,025
Closed -$440K 1772
2016
Q4
$440K Buy
18,025
+5,525
+44% +$158K ﹤0.01% 1178
2016
Q3
$474K Buy
+12,500
New +$393K ﹤0.01% 749

Other funds holding RCKT